Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals Limited has submitted a credit rating announcement to the NSE, as required under listing obligations. The specific rating action — whether it is an upgrade, downgrade, or revision in outlook — and the rating agency involved are not detailed in the headline. The filing signals a change or reaffirmation in the company's credit profile, which may affect its borrowing costs and investor perception. Shareholders should look for the detailed rating agency press release for the actual rating and rationale.
The direct impact on the stock depends on the direction of the rating action; any downgrade could pressure the share price and increase future borrowing costs, while an upgrade or stable reaffirmation would be neutral to positive.